The Hematology-Oncology Fellowship training program at Jackson Memorial Hospital, in affiliation with the University of Miami’s Sylvester Comprehensive Cancer Center prepares academically oriented physicians to become leaders in clinical teaching and in clinical and laboratory research.
The Hematology/Oncology Fellowship training program offers a well-integrated fellowship training program which leads to eligibility for the Hematology and/or Oncology Board Examination after a three-year training program. The fellowship program is accredited by ACGME. The combined program for Hematology and Oncology Board Certification includes the mandatory 18-months of clinical rotations over a 36-month fellowship. The remainder of time is distributed among research time (basic or clinical/translational research), elective rotations and vacation.
The Hematology/Oncology fellowship program offers a broad exposure to hematologic and oncologic diseases in the in-patient and outpatient settings at three allied hospitals: University of Miami Hospital, Sylvester Comprehensive Cancer Center, and Jackson Memorial Hospital.
ACGME Accredited: yes
Residents or Fellows per year: Five
Duration: Three Years
Postgraduate Training Required: successful completion of ACGME accredited Internal Medicine Residency
U.S. Citizenship Required: accepts J-1 Visa
Residents/Fellows who have graduated our program in the last 10 years obtained faculty positions at:
- Yale University
- University of Pennsylvania
- University of Miami
- University of Oklahoma
- University of Louisville
- Karamanos Cancer Center
- Dana Farber Cleveland Clinic Moffit Cancer Center Tulane University
- Universidad Javeriana
- University of Wisconsin-Madison
- Johns Hopkins
- Jackson Memorial Hospital,Sylvester Comprehensive Cancer Center
- University ofMiami Hospital
The Jackson Memorial Hospital Hematology/Oncology Fellowship Training Program selects fellows through the National Residency Matching Program (NRMP). All fellowship applicants should have completed an ACGME-accredited internal medicine program. All applicants must submit their applications via ERAS. U.S. citizens, permanent residents, or physicians under J-1 visa (exchange visitor program) can apply to our fellowship program.
All applicants must submit their applications via ERAS.
During the first year the fellow will finish the in-patient hematology/oncology Core Rotations at SCCC and JMH. The fellow will select Structured Electives that will offer a broad range of experience with different SDGs and introduce them to many members of the faculty. During this time the first year fellow will decide what their career goals are with the help of their mentor and formulate a plan to attain them. By the end of their first year or during the first six months of their second year the fellow will be able to select one of four fellowship tracks.
Defined Fellowship Pathways
Clinical Research Track-designed to enable the career development of a clinical investigator
- Fellow is mentored by a clinical investigator o Fellow is expected to write a clinical trial
- Fellow should attend IRB and Protocol Review Committee meetings
- Fellow should attend ASCO/AACR/ESMO clinical research workshop (or similar meeting)
- Fellow should take a clinical statistics course at University of Miami
- Consider a fourth year as an instructor and completion of Master’s of Science in
- Clinical and Translational Investigation (MSCTI)
- Public Health/Global Health/Health Equities Track-designed for the Oncology Fellow who has a passion for epidemiology, global health or disparity research
- Fellow will enroll in the University of Miami MPH program o Fellow will have a public health oncology thesis project
- Laboratory/Translational Track
- Fellow will front load all clinical requirements in the first year or 18 months. The last two years to 18 months will be focused on a laboratory-based project.
- Fellow will attend AACR molecular workshop (or similar meeting)
- Fellow will take Cancer Biology course and any other courses pertinent to their project
- Consider MS in Cancer Biology
- Fellow may opt for single board certification option ie: Oncology only, Hematology only or pursue a fourth year as an clinical instructor
- Clinical Track-designed for the fellow who is intellectually curious but does not want a career in academic medicine
- Will have two JMH clinics/week during the Second Year and three JMH clinics/week during Third year
- Will have Sylvester Comprehensive Cancer Center continuity clinics in Second and
- Must lead Q/A projects each year
Board Exam Requirements
Must be board certified or eligible in Internal Medicine
Educational & Other Experience
- Research Opportunities
The Sylvester Comprehensive Cancer Center is at the forefront of advanced new treatments and cutting edge technology. This allows our team of cancer experts to develop and pioneer highly innovative strategies to fight some of the most aggressive and deadly forms of cancer. There are more than 250 physicians and scientists dedicated to cancer care and research. Every day, our physicians and scientists within the cancer center’s 15 site disease groups and seven multidisciplinary research programs, are discovering exciting new breakthroughs that are quickly transforming the way cancer patients are diagnosed and treated. Translating research breakthroughs into more effective treatments remains one of Sylvester’s highest priorities. Sylvester conducts more clinical research than any other institution in South Florida and has a wide range of trials, with 168 currently underway.
Scientists at Sylvester are grouped into seven multidisciplinary research programs
- Biobehavioral Oncology Program
- Molecular Oncology and Experimental Therapeutics Program
- Tumor lmmunobiology Program
- Viral Oncology Program
- Breast Cancer Program
- Cancer Epidemiology & Prevention Program
Genitourinary Malignancies Program
The fellows are expected to develop research projects during their training. Projects are tailored to each fellow’s interests and can include anything from basic science research to design of a clinical trial or clinical outcomes research. During the first year the fellow will identify a mentor and with their guidance devise an appropriate research project that can be completed by the end of their fellowship. The fellow will meet on a regular basis with mentor and the fellowship director to determine progress on their project. Fellows are expected to present and/or publish the results of their work in a peer reviewed journal. Research electives may also be developed in conjunction with clinical or laboratory faculty research mentors.
Miami Clinical and Translational Science Institute (CTSI)
Created in 2012, the Miami Clinical and Translational Science Institute (CTSI) drives research translation into evidence-based clinical and community practices that improve the health of South
Florida’s diverse population.
In a community comprised of 85 percent racial and ethnic minorities, the Miami CTSI makes significant contributions in minority health and health disparities and in training underrepresented minorities in clinical, translational, and community-engaged research.
The Miami CTSJ educates, connects, and supports research teams by building the distinct science of clinical translational research, fostering collaboration, and managing the resources needed to
sustain success in these areas.
Made up of the University of Miami, Jackson Memorial Health System, and Miami VA Healthcare System, we are jointly funded by the NIH National Center for Advancing Translational Sciences and the National institute on Minority Health and Health Disparities. The Miami CTSI is member of the
National Clinical and Translational Science Award (CTSA) Consortium, a prestigious group of 61 world-class academic research institutions that is transforming the way biomedical research is conducted across the country.
The Miami Clinical and Translational Science Institute offers a Master’s of Science in Clinical and Translational Investigation. This structured educational program offers trainees of diverse cultural and educational backgrounds formal graduate training in the principles and practice of translational science and clinical research.
This program provides a foundation for the development of future practitioners and leaders of translational science who are prepared to deal with the perceived bottlenecks that inhibit
translational research: institutional culture and practice, scientific complexity of translational research design and methodology, and regulatory and ethical processes.
The mission of this curriculum development program is to engage promising new and early stage investigators in the discipline of translational science, so that they make the pursuit of academic translational science their own professional goal.
There is no in house call.
Judith Hurley, M.D.
Pasquale W. Benedetto, M.D.
Associate Program Director, Oncology
James Hoffman, M.D.
Associate Program Director, Hematology